跳至主要内容
临床试验/CTRI/2025/02/080149
CTRI/2025/02/080149尚未招募不适用

Effectiveness of Vasadi Dravya Kashaya, Sarasijamakarandadi Choorna, Virechana in the management of Asrgdara- A Comparative Clinical Study

Dr Anagha S2 个研究点 分布在 1 个国家目标入组 135 人开始时间: 2025年2月27日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
135
试验地点
2
主要终点
Effectiveness of Vasadi Dravya Kashaya, Sarasijamakarandadi choorna, Virechana in the management of Asrgdara

研究概览

简要总结

Asrgdara is characterized by excessive and prolonged blood loss during menstruation. It is caused due to the excessive indulgence in Vata-Pitta vardhaka ahara and vihara which leads to the quantitative increase of rakta in the garbhasaya gatha sira and in turn leading to increase in the amount of artava. If Asrgdara is not treated properly, it can lead to various complications like dourbalya, bhrama, murcha, pandutva, and severe disorders of vata ¹ Asrgdara with its signs and symptoms can be correlated with Dysfunctional uterine bleeding (DUB). The term DUB refers to a state of abnormal uterinebleeding without any clinically detectable organic, systemic and iatrogenic causes. This condition is reported to occur in 9-14% women between menarche and menopause. For excessive bleeding in modern medicine treatment modalities like hormonal therapy, prostaglandin synthetase inhibitors, anti fibrinolytic agents, surgical interventions like ablative techniques, hysterectomy, etc. are prescribed. But these are expensive and have limitations in treatment of reproductive age group. Hence there is a need to adopt a harmless therapy, which is easily available, cost effective and to cure Asrgdara. The first line of treatment for Asrgdara is to control the excessive bleeding and the drugs should be mainly sheeta virya, tikta, kashaya rasa which acts as stambhaka. This study have been designed in such a way to find out the clinical efficacy of effectiveness of Vasadi dravya kashaya, Sarasijamakarandadi Choorna, Virechana in the management of Asrgdara.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 40.00 Year(s)(—)
性别
Female

入选标准

  • Menstrual bleeding for more than five days in each cycle Intermenstrual bleeding Patient using more than three completely soaked pads per day Subjects with signs and symptoms of Asrgdara for atleast three months Subjects aged between 18-40years Both married and unmarried Subjects who are fit for Virechana randomly taken for the study Subjects willing to sign informed consent.

排除标准

  • Subjects who are having Coagulation disorders or bleeding disorders Subjects using Intra uterine contraceptive device or contraceptive pills Systemic illnesses like DM,HTN , Hyperthyroidism Subject with known case of malignant growth in uterus or any organic pathology like cervical erosion, fibroid uterus,adenomyosis, PID Subjects whose Hb% is less than 8gm%.

结局指标

主要结局

Effectiveness of Vasadi Dravya Kashaya, Sarasijamakarandadi choorna, Virechana in the management of Asrgdara

时间窗: 30th, 60th, 90th, 120th,150th day

次要结局

  • Effectiveness of Vasadi Dravya Kashaya, Sarasijamakarandadi choorna, Virechana in the management of Asrgdara(30th,60th,90th day)

研究者

发起方
Dr Anagha S
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Anagha S

SDM College of Ayurveda

研究点 (2)

Loading locations...

相似试验